Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filing in the gaps.

Over the summer, we took a deep dive into “Ozempic Face,” a phenomenon that occurs when quick, significant weight loss leads ...

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

A recent CDC report indicated that the U.S. obesity rates may have dropped after over a decade-long rise last year, a finding ...

These UK stocks look set to benefit from favourable demographics over the next decade so Edward Sheldon is planning to hold ...

These new challengers are anticipated to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion by 2031. Our report on the obesity drug market ...

Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being “extremely effective” ...